DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,960
+360 (3.40%)
At close: Sep 4, 2026

DAE HWA Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,1461,3571,6584,3503,1254,002
Short-Term Investments
3,3003,3005,1007,6203,24011,340
Trading Asset Securities
2,1081,4451,1041,4891,5973,080
Cash & Short-Term Investments
7,5536,1027,86313,4587,96218,422
Cash Growth
11.41%-22.39%-41.58%69.03%-56.78%49.05%
Accounts Receivable
23,49919,30620,38322,75518,13716,719
Other Receivables
851.2966.011,0061,4221,3131,517
Receivables
24,35020,27221,38924,17619,45018,236
Inventory
34,70835,18331,34026,67823,41318,682
Prepaid Expenses
615.63669.01480.34310.27294.59287.91
Other Current Assets
188.12132.6534.76597.2392.92511.03
Total Current Assets
67,41662,35961,60765,22051,21356,139
Property, Plant & Equipment
86,98588,84791,70294,35189,85768,245
Long-Term Investments
9,7234,8693,79810,92910,4758,639
Goodwill
693.16693.16693.16693.16693.16693.16
Other Intangible Assets
29,47429,60828,63027,82226,97223,775
Long-Term Deferred Tax Assets
6,2394,5803,6223,9923,6424,172
Other Long-Term Assets
19,80719,90815,83116,15416,20415,713
Total Assets
220,337210,863205,884219,163199,056177,376

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12,99113,58811,59715,78312,9258,026
Accrued Expenses
2,6922,6592,5592,6692,9581,504
Short-Term Debt
64,07961,62859,19974,45759,05556,347
Current Portion of Long-Term Debt
30,52131,19534,23828,1893,2502,500
Current Portion of Leases
145.58122.61117.78149.65201.76238.02
Current Income Taxes Payable
720.31231.246.2627.35380.051,463
Current Unearned Revenue
31.1142.3542.3542.3550.1969.05
Other Current Liabilities
9,84312,0199,8936,6314,4405,189
Total Current Liabilities
121,023121,484117,693127,94883,26075,335
Long-Term Debt
7,0093,6905,5667,50027,30710,796
Long-Term Leases
200.81139.96151.94229.92251.93269.24
Pension & Post-Retirement Benefits
3,6373,7263,7703,6763,2754,402
Other Long-Term Liabilities
2,7432,6822,3342,4573,2713,157
Total Liabilities
134,613131,722129,515141,809117,36593,960

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
9,3089,3089,3089,3089,3089,308
Additional Paid-In Capital
39,55135,55633,02333,02333,02333,023
Retained Earnings
39,32738,31939,38341,56245,86246,529
Treasury Stock
-1,618-7,573-9,162-9,162-9,162-9,162
Comprehensive Income & Other
-5,948-1,537-554.04-1,500-1,040-24.6
Total Common Equity
80,62174,07371,99973,23277,99379,674
Minority Interest
5,1035,0694,3714,1213,6993,742
Shareholders' Equity
85,72479,14276,37077,35381,69183,416
Total Liabilities & Equity
220,337210,863205,884219,163199,056177,376

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
101,95696,77699,274110,52590,06670,150
Net Cash (Debt)
-94,403-90,674-91,411-97,067-82,104-51,728
Net Cash Growth
------
Net Cash Per Share
-5279.37-5172.72-5160.42-5541.39-4687.19-2962.69
Filing Date Shares Outstanding
18.4217.917.5217.5217.5217.52
Total Common Shares Outstanding
18.4217.917.5217.5217.5217.52
Working Capital
-53,608-59,125-56,085-62,728-32,047-19,196
Book Value Per Share
4376.244137.764110.334180.704452.484548.48
Tangible Book Value
50,45443,77142,67644,71750,32755,206
Tangible Book Value Per Share
2738.712445.092436.302552.812873.103151.65
Land
-15,65918,96419,09719,09719,097
Buildings
-66,86567,44067,14445,06545,065
Machinery
-69,55462,37156,98342,93644,633
Construction In Progress
-847.17470.042,76529,5493,035